- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 624563, 6 pages
Role of Corneal Epithelium in Riboflavin/Ultraviolet-A Mediated Corneal Cross-Linking Treatment in Rabbit Eyes
1Department of Ophthalmology, Shandong Provincial Hospital Affiliated to Shandong University, No. 324, Jing 5 Road, Jinan, Shandong 250021, China
2Department of Ophthalmology, Affiliated Hospital of Weifang Medical College, Weifang, Shandong 261000, China
3Department of Visual Sciences and Ophthalmology, The Chinese University of Hong Kong, Shatin, Hong Kong
4Centre for Eye Research Australia, University of Melbourne, Melbourne, VIC, Australia
Received 15 April 2013; Accepted 11 June 2013
Academic Editor: Vasilios F. Diakonis
Copyright © 2013 Xiangchen Tao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Purpose. To evaluate the role of corneal epithelium in riboflavin/ultraviolet-A (UVA) mediated corneal collagen cross-linking treatment. Methods. Fifty New Zealand rabbits were divided into 5 groups: UVA treatment with or without corneal epithelium, UVA+riboflavin treatment with or without corneal epithelium, and control without any treatment. All rabbits were sacrificed after irradiation and subsequently 4 mm × 10 mm corneal strips were harvested for biomechanical evaluation. Results. UVA irradiation alone did not enhance the maximal stress and Young’s modulus of corneal specimens with (3.15 ± 0.56 mpa, 1.00 ± 0.09 mpa) or without (3.53 ± 0.85 mpa, 0.94 ± 0.21 mpa) the corneal epithelium, compared to specimens in the control group (4.30 ± 0.68 mpa, 1.03 ± 0.24 mpa). However, UVA irradiation combined with riboflavin significantly increased the maximal stress and Young’s modulus of corneal specimens with (5.27 ± 1.09 mpa, 1.23 ± 0.23 mpa, ) or without (7.16 ± 1.88 mpa, 1.42 ± 0.16 mpa, ) corneal epithelium when compared to the control group. The maximal stress and Young’s modulus of cornea in UVA+riboflavin and “epithelium-off” group were 35.9% and 15.4% higher compared to the UVA+riboflavin and “epithelium-on” group, respectively (). Conclusions. Our study shows that UVA+riboflavin treatment significantly affects the biomechanical properties of the cornea with and without epithelial removal. However, corneas without epithelium seem to benefit more compared to corneas with the epithelium.
Keratoconus is a noninflammatory, chronic progressive corneal disorder with an incidence of approximately 1 in 2,000 . The clinical signs of keratoconus include stromal thinning followed by a cone-like protrusion of the cornea, which in turn induces progressive irregular astigmatism. In late stages of keratoconus, breaks in the Descemet’s layer may lead to acute corneal hydrops which aggravates visual impairment. Common treatments included contact lenses and glasses, intracorneal rings, photorefractive keratectomy (PRK), and corneal transplantation [2, 3]. However, these treatment modalities do not retard or terminate the progression of keratoconus.
In 2003, Wollensak et al. reported riboflavin/ultraviolet-A- (UVA) induced collagen cross-linking (CXL) for stabilization of keratoconus . In Wollensak’s study, 70% of the eyes had a 2.01 diopters reduction in keratometry and 1.14 diopters reduction in refraction. An additional 60% of the eyes had a slight improvement in visual acuity. The transparency of the cornea and the lens, endothelial density, and intraocular pressure remained unchanged. The study demonstrated that cross-linking is a viable treatment modality that impedes the progression of keratoconus . It was further demonstrated in an experimental model that riboflavin-UVA-induced collagen cross-linking led to an increase in mechanical rigidity in porcine corneas and an even greater increase in human corneas .
The conventional protocol for CXL is to remove the corneal epithelium before UVA irradiation. Previous studies [6–8] have demonstrated an enhancement of riboflavin penetration into the corneal stroma after removal of corneal epithelium. In the current study, we aim to determine the role of corneal epithelium in CXL by comparative evaluation of biomechanical properties of cornea after riboflavin/ ultraviolet-A-induced CXL treatment with or without corneal epithelium.
2.1. Animal Model
Fifty New Zealand rabbits (weight 2.0–2.5 kg, age 4-5 months), acquired from the Shandong Academy of Agricultural Sciences, were divided into 5 groups: UVA with (UVA epi-on) or without (UVA epi-off) corneal epithelium, UVA+riboflavin with (CXL epi-on) or without (CXL epi-off) corneal epithelium, and controls (without any treatment). The living environment of the experimental animals was maintained at 21°C with a 12-hour light and dark cycle. All rabbits were fed ad libitum. Animals used in this study were treated in accordance with the Shandong University Animal Experimentation Ethic Committee (AEEC) guidelines. The study protocol was approved by the AEEC. All treatments were performed on the left eyes only.
2.2. Collagen Cross-Linking
The animals were anesthetized with intramuscular injection of 0.2-0.3 mL/kg xylazine (Hua Mu Animal Health Products, China) and intravenous injection with 0.5 mL diazepam (Jin Yao Amino Acid, China). Baseline thickness of the cornea was measured using a corneal pachymeter (DGH 550, DGH Technology Inc., USA). In the epi-off groups, central 8.5 mm corneal epithelium was scraped off with a scalpel. 0.1% riboflavin sodium phosphate was prepared by dissolving riboflavin sodium phosphate solution (Jiang’Xi pharmaceutical Co. Ltd., China) in distilled water. Distilled water was used instead of riboflavin in the control group. Riboflavin solution or distilled water (control group) was topically administered onto the cornea for a period of 30 minutes at an interval of 2 minutes. Subsequently, the cornea was illuminated with an ultraviolet light for 30 minutes using a UVA lamp (UVX 1000 system, IROC Innocross AG Co. Ltd., Switzerland) (wavelength 365 nm, irradiance 3.0 mW/cm2, total dose 5.4 J/cm2). Riboflavin administration was continued every 2 minutes during UV illumination. The same surgical procedure was undertaken in the epithelium-on group without removal of the corneal epithelium.
2.3. Evaluation of Corneal Biomechanical Properties
The rabbits were sacrificed by air embolism immediately after cross-linking procedure. For the preparation of the corneal strips, corneoscleral ring of the enucleated eyes was cut off in a circular manner and a 4.0 mm × 10.0 mm vertical corneal strip was removed from the 12 o’clock position with a scalpel. The corneal thickness was determined using a mechanical micrometer caliper. The corneal strips were clamped horizontally between the jaws of a commercially available microcomputer-controlled biomaterial-testing device with a distance of 8.0 mm () between the jaws (Instron 5544 system, Instron Co. Ltd., USA) (Figure 1). The strain displacement was increased linearly at a rate of 2.0 millimeter/minute and was measured up to the point of tissue rupture. A curve for relationship between the load () and displacement () was obtained. As suggested previously , the data in the range of 0–0. 04 N were selected to calculate the stress using the equation , where is the corneal thickness, and the related strain was obtained by . Young’s modulus was calculated by using the equation . The ultimate stress was measured at the tearing point. The ultimate strain was measured as a percentage of the starting length of the strip, represented by the amount of elongation at the point of tissue rupture.
Hematoxylin and eosin (H & E) staining was used to verify the success of epithelial removal and the presence of an intact Descemet’s membrane.
2.4. Statistical Analysis
One way ANOVA was performed with MedCalc (Version 22.214.171.124) to compare the difference of maximal stress and Young’s modulus between different groups.
The average corneal thickness before epithelial debridement was 361 ± 15 μm. There were no significant differences between the baseline central corneal thicknesses before UVA treatment in any of the groups. Histopathological analysis showed a successful removal of corneal epithelium in specified groups and an intact Descemet’s membrane in all samples (Figure 2).
UVA irradiation alone did not enhance the maximal stress and Young’s Modulus of corneal specimens with (3.15 ± 0.56 mpa, 1.00 ± 0.09 mpa) or without (3.53 ± 0.85 mpa, 0.94 ± 0.21 mpa) corneal epithelium compared to the specimens in the control group (4.30 ± 0.68 mpa, 1.03 ± 0.24 mpa) (Figures 3 and 4). However, UVA irradiation combined with riboflavin significantly increased the maximal stress and Young’s modulus of corneal specimens with (5.27 ± 1.09 mpa, 1.23 ± 0.23 mpa, ) or without (7.16 ± 1.88 mpa, 1.42 ± 0.16 mpa, ) the corneal epithelium compared to the control group (Figures 3 and 4). The maximal stress and Young’s modulus of cornea in UVA+riboflavin+epithelium-off group were 35.9% and 15.4% higher compared to the UVA+riboflavin+epithelium-on group, respectively ().
As a soft biological tissue, cornea shares some properties of viscoelastic materials which can be evaluated by stress-strain curve, Young’s modulus, and corneal hysteresis. Young’s modulus is a major indicator of the elastic properties of cornea. It reflects the ability of a cornea to return to its original shape after being under stress. It has also been proposed to reflect the severity of corneal ectatic disorders such as keratoconus .
The last decade has seen a prominent increase in the popularity of CXL as a therapeutic measure to retard the progression of keratoconus. The stiffening of the upper 200–300 μm of the corneal stroma is achieved through a photooxidative induction of collagen cross-links. The evidence of efficacy of CXL is supported by laboratory studies documenting the biomechanical and cellular changes induced by cross-linking [11, 12], as well as satisfying outcomes of CXL in the clinical practice [4, 13, 14]. Animal studies have elaborated that changes in the biomechanical properties of cornea after CXL were related to the irradiation time , light energy density, and riboflavin absorption , as well as animal species as evident by a greater increase of cornea rigidity in humans compared to porcine corneas . Besides the optimized UVA and riboflavin solution parameters, the standard protocol for CXL  involves the removal of central 9 mm of corneal epithelium before riboflavin administration, and UVA irradiation. Recently, Kymionis et al. have demonstrated better visual and refractive outcomes after CXL combined with epithelial removal using t-PTK than after mechanical epithelial debridement .
However, considering the complications associated with the removal of corneal epithelium, most notably pain, risk of infection and postoperative corneal haze, an evaluation of the necessity of this step during CXL is desirable in clinical practice. Some surgeons have modified the standard protocol and performed the treatment without removing the epithelium [19–22]. In a study by Wollensak and Iomdina , there was a statistically significant increase in Young’s modulus in corneas treated with standard CXL as compared to the epithelium-on corneas cross-linked with the addition of benzalkonium chloride-containing proxymetacaine eye drops. The authors proposed that corneal cross-linking without epithelial debridement reduced the biomechanical effect by approximately one-fifth compared to standard cross-linking probably due to restricted and inhomogeneous stromal distribution of riboflavin. Baiocchi et al.  showed that stromal concentrations of riboflavin increased with exposure time only if the corneal epithelium was removed. In our study we found a statistically significant increase in Young’s modulus as well as the maximal stress in both epithelium- “on” and “-off” corneas. Further, we found that the maximal stress and Young’s modulus of the corneal specimens in the epithelium-off group were 35.9% and 15.4% higher, respectively, than those in the epithelium-on group after riboflavin and UVA combination treatment. The enhanced effect of CXL in corneas without the epithelium is expected due to the absence of an intact epithelium in these eyes which would otherwise impair the absorption of riboflavin .
Kissner et al.  found that treatment with benzalkonium chloride 0.02% induces sufficient epithelial permeability for the passage of riboflavin as compared to the standard protocol. Raiskup et al.  demonstrated that addition of 0.01% benzalkonium chloride and 0.44% sodium chloride to riboflavin solution promotes its permeability through the epithelium, resulting in a sufficient concentration of riboflavin in the corneal stroma. In addition to the permeability issues of riboflavin through an intact corneal epithelium, the presence of epithelium represents a barrier for UVA penetration which is essential for a successful CXL procedure. It is possible that the UVA energy delivered through “epithelium-on” is different compared to the standard “epithelium-off” procedure .
In our study, the morphological analysis using H & E staining showed that the density of keratocytes and collagen fibers had no significant changes in CXL groups with or without corneal epithelium compared with that in control group (data not shown here). Mencucci et al.  reported that the diameter of corneal collagen fiber in CXL treated human corneal buttons increased by 22.6% compared with that in control group at 6 months postoperatively. In the present study, the corneas were harvested within 1 hour after CXL treatment, and therefore the pathological changes of cornea could not be identified with techniques used in our study. Considering the significant enhancement of corneal biomechanical properties in the very early stage after CXL, more specific and sensitive markers should be investigated to evaluate the pathological changes of cornea immediately after CXL treatment. Few clinical studies [28, 29] have attempted to evaluate the safety and efficacy of transepithelial CXL in cases with keratoconus. However, these studies are limited by small sample size, limited follow-up, and lack of comparative groups.
There are a few limitations of the present study. Corneas were retrieved early after the CXL procedure. Distilled water was used as a solvent for riboflavin in our study to match the control groups, as opposed to dextran which is being used in the commercial preparation of riboflavin. Application of hypotonic riboflavin solution without dextran during cross-linking procedure may alter the permeability of riboflavin and therefore lead to different results as compared to the standard riboflavin/dextran solution. Exposure of corneal epithelium to hyposmolar distilled water for 30 minutes may compromise the cell-cell tight junction integrity thereby potentially increasing permeability to the riboflavin solution . This may explain a significantly improved biomechanical response compared with the control in our study even with an intact corneal epithelium (albeit less than that produced following epithelial removal). We did not evaluate the permeability of the riboflavin solution into the corneal stroma. Future studies can focus on evaluation of biomechanical properties of the corneas using other carriers which are being used for transepithelial CXL. It is noteworthy that the rabbit cornea lacks Bowman’s membrane which is a possible barrier for the permeation of riboflavin during CXL procedure. Further studies should evaluate whether injury to the Bowman’s membrane during epithelial removal will affect the outcome of CXL. Also, the rabbit corneas in their study were normal and not keratoconic.
Our study provides direct evidence of the effect of CXL procedure on corneal biomechanical properties. This effect was significantly enhanced after the removal of corneal epithelium during CXL.
This study is supported by funds provided by the Health Department of Shandong Province, China, no. 2011HW059, and the Department of Science and Technology of Shandong Province, China, no. BS2012YY026.
- V. Jhanji, N. Sharma, and R. B. Vajpayee, “Management of keratoconus: current scenario,” British Journal of Ophthalmology, vol. 95, no. 8, pp. 1044–1050, 2011.
- W. Sekundo and J. D. Stevens, “Surgical treatment of keratoconus at the turn of the 20th century,” Journal of Refractive Surgery, vol. 17, no. 1, pp. 69–73, 2001.
- J. Colin, B. Cochener, G. Savary, and F. Malet, “Correcting keratoconus with intracorneal rings,” Journal of Cataract and Refractive Surgery, vol. 26, no. 8, pp. 1117–1122, 2000.
- G. Wollensak, E. Spoerl, and T. Seiler, “Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus,” American Journal of Ophthalmology, vol. 135, no. 5, pp. 620–627, 2003.
- G. Wollensak, E. Spoerl, and T. Seiler, “Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking,” Journal of Cataract and Refractive Surgery, vol. 29, no. 9, pp. 1780–1785, 2003.
- K. M. Bottós, P. Schor, J. L. Dreyfuss, H. B. Nader, and W. Chamon, “Effect of corneal epithelium on ultraviolet-A and riboflavin absorption,” Arquivos Brasileiros de Oftalmologia, vol. 74, no. 5, pp. 348–351, 2011.
- K. Samaras, D. P. O'Brart, J. Doutch, S. Hayes, J. Marshall, and K. M. Meek, “Effect of epithelial retention and removal on ribofl avin absorption in porcine corneas,” Journal of Refractive Surgery, vol. 25, no. 9, pp. 771–775, 2009.
- S. Hayes, D. P. O'Brart, L. S. Lamdin et al., “Effect of complete epithelial debridement before riboflavin-ultraviolet-A corneal collagen crosslinking therapy,” Journal of Cataract and Refractive Surgery, vol. 34, no. 4, pp. 657–661, 2008.
- C. Weiyi, X. Wang, C. Wang, L. Tao, X. Li, and Q. Zhang, “An experimental study on collagen content and biomechanical properties of sclera after posterior sclera reinforcement,” Clinical Biomechanics, vol. 23, supplement 1, pp. S17–S20, 2008.
- A. Gefen, R. Shalom, D. Elad, and Y. Mandel, “Biomechanical analysis of the keratoconic cornea,” Journal of the Mechanical Behavior of Biomedical Materials, vol. 2, no. 3, pp. 224–236, 2009.
- R. Mencucci, M. Marini, I. Paladini et al., “Effects of riboflavin/UVA corneal cross-linking on keratocytes and collagen fibres in human cornea,” Clinical and Experimental Ophthalmology, vol. 38, no. 1, pp. 49–56, 2010.
- S. Kling, L. Remon, A. Pérez-Escudero, J. Merayo-Lloves, and S. Marcos, “Corneal biomechanical changes after collagen cross-linking from porcine eye inflation experiments,” Investigative Ophthalmology & Visual Science, vol. 51, no. 8, pp. 3961–3968, 2010.
- A. Caporossi, S. Baiocchi, C. Mazzotta, C. Traversi, and T. Caporossi, “Parasurgical therapy for keratoconus by riboflavin-ultraviolet type A rays induced cross-linking of corneal collagen. Preliminary refractive results in an Italian study,” Journal of Cataract and Refractive Surgery, vol. 32, no. 5, pp. 837–845, 2006.
- F. Raiskup-Wolf, A. Hoyer, E. Spoerl, and L. E. Pillunat, “Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: Long-term results,” Journal of Cataract and Refractive Surgery, vol. 34, no. 5, pp. 796–801, 2008.
- E. Lanchares, M. A. del Buey, J. A. Cristóbal, L. Lavilla, and B. Calvo, “Biomechanical property analysis after corneal collagen cross-linking in relation to ultraviolet A irradiation time,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 249, no. 8, pp. 1223–1227, 2011.
- S. Schumacher, M. Mrochen, J. Wernli, M. Bueeler, and T. Seiler, “Optimization model for UV-riboflavin corneal cross-linking,” Investigative Ophthalmology & Visual Science, vol. 53, no. 2, pp. 762–769, 2012.
- E. Spoerl, M. Mrochen, D. Sliney, S. Trokel, and T. Seiler, “Safety of UVA-riboflavin cross-linking of the cornea,” Cornea, vol. 26, no. 4, pp. 385–389, 2007.
- G. T. Kymionis, M. A. Grentzelos, G. A. Kounis, V. F. Diakonis, A. N. Limnopoulou, and S. I. Panagopoulou, “Combined transepithelial phototherapeutic keratectomy and cornal collagen cross-linking for progressive keratoconus,” Ophthalmology, vol. 119, no. 9, pp. 1777–1784, 2012.
- A. Ertan, H. Karacal, and G. Kamburoǧlu, “Refractive and topographic results of transepithelial cross-linking treatment in eyes with intacs,” Cornea, vol. 28, no. 7, pp. 719–723, 2009.
- L. L. Vicente and B. S. Boxer Wachler, “Factors that correlate with improvement in vision after combined Intacs and trans-epithelial corneal crosslinking,” British Journal of Ophthalmology, vol. 94, no. 12, pp. 1597–1601, 2010.
- A. Leccisotti and T. Islam, “Transepithelial corneal collagen cross-linking in keratoconus,” Journal of Refractive Surgery, vol. 26, no. 12, pp. 942–948, 2010.
- M. M. Al Marzouky, H. I. El-Shawaf, and R. Pinelli, “Tensioactive-mediated transepithelial corneal cross-linking-first laboratory report,” European Ophthalmic Review, vol. 3, no. 2, pp. 67–70, 2009.
- G. Wollensak and E. Iomdina, “Biomechanical and histological changes after corneal crosslinking with and without epithelial debridement,” Journal of Cataract and Refractive Surgery, vol. 35, no. 3, pp. 540–546, 2009.
- S. Baiocchi, C. Mazzotta, D. Cerretani, T. Caporossi, and A. Caporossi, “Corneal crosslinking: riboflavin concentration in corneal stroma exposed with and without epithelium,” Journal of Cataract and Refractive Surgery, vol. 35, no. 5, pp. 893–899, 2009.
- A. Kissner, E. Spoerl, R. Jung, K. Spekl, L. E. Pillunat, and F. Raiskup, “Pharmacological modification of the epithelial permeability by benzalkonium chloride in UVA/Riboflavin corneal collagen cross-linking,” Current Eye Research, vol. 35, no. 8, pp. 715–721, 2010.
- F. Raiskup, R. Pinelli, and E. Spoerl, “Riboflavin osmolar modification for transepithelial corneal cross-linking,” Current Eye Research, vol. 37, no. 3, pp. 234–238, 2012.
- L. Kolozsvári, A. Nógrádi, B. Hopp, and Z. Bor, “UV absorbance of the human cornea in the 240- to 400-nm range,” Investigative Ophthalmology & Visual Science, vol. 43, no. 7, pp. 2165–2168, 2002.
- M. Filippello, E. Stagni, and D. O'Brart, “Transepithelial corneal collagen crosslinking: bilateral study,” Journal of Cataract and Refractive Surgery, vol. 38, no. 2, pp. 283–291, 2012.
- A. Caporossi, C. Mazzotta, S. Baiocchi, T. Caporossi, and A. L. Paradiso, “Transepithelial corneal collagen crosslinking for keratoconus: qualitative investigation by in vivo HRT II confocal analysis,” European Journal of Ophthalmology, vol. 22, supplement 7, pp. S81–S88, 2012.
- T. A. Alhamad, D. P. S. O'Brart, N. A. L. O'Brart, and K. M. Meek, “Evaluation of transepithelial stromal riboflavin absorption with enhanced riboflavin solution using spectrophotometry,” Journal of Cataract and Refractive Surgery, vol. 38, no. 5, pp. 884–889, 2012.